Alexander Desuki

827 total citations
16 papers, 69 citations indexed

About

Alexander Desuki is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Alexander Desuki has authored 16 papers receiving a total of 69 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Alexander Desuki's work include CAR-T cell therapy research (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Cancer Genomics and Diagnostics (3 papers). Alexander Desuki is often cited by papers focused on CAR-T cell therapy research (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Cancer Genomics and Diagnostics (3 papers). Alexander Desuki collaborates with scholars based in Germany, Netherlands and Austria. Alexander Desuki's co-authors include Daniel Heudobler, Peter Borchmann, Benjamin Rengstl, Andréas Mackensen, Liane Preußner, Eva Wagner-Drouet, Winfried Alsdorf, Christian Koenecke, Erol Wiegert and Uğur Şahin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Alexander Desuki

14 papers receiving 69 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexander Desuki Germany 6 36 35 25 11 10 16 69
Neeharika Kothapalli United States 4 44 1.2× 22 0.6× 37 1.5× 8 0.7× 9 0.9× 8 88
Emin Onur Karakaslar Netherlands 5 46 1.3× 11 0.3× 24 1.0× 7 0.6× 7 0.7× 8 92
Siok Ping Yeo Singapore 4 48 1.3× 42 1.2× 28 1.1× 15 1.4× 10 1.0× 4 98
Erin E. Tapper United States 5 34 0.9× 61 1.7× 13 0.5× 11 1.0× 11 1.1× 13 75
Kimberly Veliz United States 3 81 2.3× 36 1.0× 17 0.7× 14 1.3× 7 0.7× 5 118
Alessio Bevilacqua Switzerland 5 44 1.2× 52 1.5× 59 2.4× 12 1.1× 11 1.1× 5 128
Nathan R. Fons United States 4 31 0.9× 25 0.7× 11 0.4× 10 0.9× 3 0.3× 5 81
Alice Piapi United Kingdom 5 37 1.0× 49 1.4× 28 1.1× 19 1.7× 13 1.3× 8 96
Agnieszka Świątkowska United Kingdom 7 51 1.4× 26 0.7× 29 1.2× 5 0.5× 6 0.6× 15 91
Ekaterina Postovalova United States 6 27 0.8× 33 0.9× 27 1.1× 15 1.4× 5 0.5× 25 98

Countries citing papers authored by Alexander Desuki

Since Specialization
Citations

This map shows the geographic impact of Alexander Desuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Desuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Desuki more than expected).

Fields of papers citing papers by Alexander Desuki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Desuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Desuki. The network helps show where Alexander Desuki may publish in the future.

Co-authorship network of co-authors of Alexander Desuki

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Desuki. A scholar is included among the top collaborators of Alexander Desuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Desuki. Alexander Desuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Rieke, Damian, Michael Bitzer, Annalen Bleckmann, et al.. (2025). Precision oncology – Guideline of the Austrian, German and Swiss Societies for hematology and medical oncology. European Journal of Cancer. 220. 115331–115331.
2.
Heilig, Christoph E., Alexander Desuki, Thomas Kindler, et al.. (2024). 198P Inavolisib in cancers with activating PIK3CA mutations: Results from the CRAFT trial. Annals of Oncology. 35. S295–S296. 1 indexed citations
4.
Mackensen, Andréas, John B.A.G. Haanen, Christian Koenecke, et al.. (2023). CLDN6 CAR-T cell therapy of relapsed/refractory solid tumors ± a CLDN6-encoding mRNA vaccine: Dose escalation data from the BNT211-01 phase 1 trial using an automated product.. Journal of Clinical Oncology. 41(16_suppl). 2518–2518. 5 indexed citations
5.
Munder, Markus, Walter Lisch, Alexander K. Schuster, et al.. (2022). Prevalence of corneal findings and their interrelation with hematological findings in monoclonal gammopathy. PLoS ONE. 17(10). e0276048–e0276048. 2 indexed citations
6.
Göbel, Sebastian, Lukas Hobohm, Alexander Desuki, et al.. (2022). Impact of cardiac amyloidosis on outcomes of patients hospitalized with heart failure. European Journal of Internal Medicine. 102. 88–96. 2 indexed citations
7.
Haanen, John B.A.G., Andréas Mackensen, Christian Koenecke, et al.. (2022). Abstract CT002: BNT211: A Phase I trial to evaluate safety and efficacy of CLDN6 CAR-T cells and CARVac-mediated in vivo expansion in patients with CLDN6-positive advanced solid tumors. Cancer Research. 82(12_Supplement). CT002–CT002. 16 indexed citations
8.
Desuki, Alexander, et al.. (2022). Successful treatment of doxorubicin-induced cardiomyopathy with low-dose sacubitril/valsartan: a case report. European Heart Journal - Case Reports. 6(10). ytac396–ytac396. 4 indexed citations
9.
Haanen, J.B.A.G., Andréas Mackensen, Christian Koenecke, et al.. (2021). LBA1 BNT211: A phase I/II trial to evaluate safety and efficacy of CLDN6 CAR-T cells and CARVac-mediated in vivo expansion in patients with CLDN6+ advanced solid tumors. Annals of Oncology. 32. S1392–S1392. 7 indexed citations
10.
Desuki, Alexander, Daniel‐Christoph Wagner, Jan Christoph, et al.. (2021). cbpManager: a web application to streamline the integration of clinical and genomic data in cBioPortal to support the Molecular Tumor Board. BMC Medical Informatics and Decision Making. 21(1). 358–358. 5 indexed citations
11.
Mackensen, Andréas, Christian Koenecke, Winfried Alsdorf, et al.. (2021). 958 BNT211: a phase I/II trial to evaluate safety and efficacy of CLDN6 CAR-T cells and vaccine-mediated in vivo expansion in patients with CLDN6-positive advanced solid tumors. SHILAP Revista de lepidopterología. A1008–A1008. 15 indexed citations
12.
Desuki, Alexander, Frank Staib, Ines Gockel, et al.. (2019). Loss ofLLGL1Expression Correlates with Diffuse Gastric Cancer and Distant Peritoneal Metastases. Canadian Journal of Gastroenterology and Hepatology. 2019. 1–12. 5 indexed citations
13.
Wasielica‐Poslednik, Joanna, Adrian Gericke, Alexander Desuki, et al.. (2018). Recurrence of paraproteinemic keratopathy after penetrating keratoplasty and its assessment with confocal microscopy. American Journal of Ophthalmology Case Reports. 11. 87–91. 4 indexed citations
14.
Lopez, Pamela Aranda, Alexander Desuki, Oliver Kriege, et al.. (2016). Ibrutinib Abrogates TREM-1 Mediated Neutrophil Activation. Blood. 128(22). 3691–3691. 1 indexed citations
15.
Lopez, Pamela Aranda, Alexander Desuki, Oliver Kriege, et al.. (2016). Idelalisib Impairs TREM-1 and TLR Mediated Neutrophil Activation. Blood. 128(22). 2510–2510. 1 indexed citations
16.
Echchannaoui, Hakim, Alexander Desuki, Alice Habermeier, et al.. (2015). Interfering with Arginine Metabolism As a New Treatment Strategy for Multiple Myeloma. Blood. 126(23). 3005–3005. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026